MARKET

AVCO

AVCO

Avalon Globocare Corp
NASDAQ
0.6410
-0.0639
-9.07%
After Hours: 0.6350 -0.006 -0.94% 19:49 09/30 EDT
OPEN
0.7900
PREV CLOSE
0.7049
HIGH
0.7900
LOW
0.6001
VOLUME
515.90K
TURNOVER
0
52 WEEK HIGH
1.150
52 WEEK LOW
0.4006
MARKET CAP
63.60M
P/E (TTM)
-6.6082
1D
5D
1M
3M
1Y
5Y
Why Senti Biosciences Shares Jumped Over 50%; Here Are 79 Biggest Movers From Yesterday
Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities initiated coverage on the stock with a Buy rating and $7 price target.
Benzinga · 2d ago
Avalon GloboCare Receives Allowance For Joint U.S. Patent
Avalon GloboCare Corp. (NASDAQ:AVCO), a leading global developer of innovative cell-based technologies and therapeutics, today provided an update regarding the Company's intellectual property portfolio featuring its
Benzinga · 2d ago
Avalon GloboCare Gets Notice of Allowance for Joint US Patent Related to QTY Fusion Water-Soluble Receptor Protein Platform
Avalon GloboCare Gets Notice of Allowance for Joint US Patent Related to QTY Fusion Water-Soluble Receptor Protein Platform
MT Newswires · 3d ago
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
Gainers
Benzinga · 4d ago
Why Bellerophon Therapeutics Shares Are Trading Higher By 24%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session
Gainers
Benzinga · 4d ago
Avalon Globocare Has Received A Notice Of Allowance For Its U.S. Patent Application 17/210,837 Titled "Qty Fc Fusion Water Soluble Receptor Proteins (For The Treatment Of Cytokine Release Syndrome)"
https://twitter.com/PatentGrants/status/1569347853348388864   https://patentcenter.uspto.gov/applications/17210837/ifw/docs
Benzinga · 09/12 15:32
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.
Benzinga · 09/07 09:16
Avalon GloboCare Announces Publication Featuring QTY Code Technology in the Official Journal of the American Chemical Society
Findings support utility of QTY protein code as a novel platform to generate water-soluble proteins for wide spectrum of biomedical applications Reports plans to apply for additional patents related to QTY code applications jointly with MIT FREEHOLD, N.J.,...
GlobeNewswire · 08/08 13:00
More
About AVCO
Avalon GloboCare Corp. is a clinical-stage, vertically integrated, CellTech bio-developer. The Company provides immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics, and therapeutics. It operates through two segments: real property and medical related consulting services. Its major clinical programs include AVA-001, AVA-011 and FLASH-CAR, ACTEX, and AVA-Trap. It also provides strategic advisory and outsourcing services to facilitate and enhance its client's growth and development, as well as competitiveness in healthcare and CellTech industry markets. Its downstream medical team and facility consists of affiliated hospital networks and experts specialized in hematology, oncology, cellular immunotherapy, hematopoietic stem/progenitor cell transplant, as well as regenerative therapeutics. Its services include research studies, executive education, daily online executive briefings, expert advisory services, and consulting and management services.

Webull offers kinds of Avalon Globocare Corp stock information, including NASDAQ:AVCO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AVCO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AVCO stock methods without spending real money on the virtual paper trading platform.